Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Of Ventricular Tachycardia Article
This is a selection made from among articles on Drug Treatment Of Ventricular Tachycardia. For a permanent link to this article, or to bookmark it for future reading, click here.
What Everyone Should Know About Addiction Treatment Programs
from: Finding the right addiction treatment program can be overwhelming. There are many different factors that play into whether or not a particular rehab program is right for you including the patient’s medical and psychiatric needs, financial status, and personal obstacles. All addiction treatment programs are different.There are hundreds of them available throughout the United States, and it can be frustrating trying to figure out which one is right for you. The referral team at Recovery Connection can help you to find an addiction treatment program that is best fitted to your needs. The service has been helping people throughout the United States find respected and appropriate addition treatment centers for years. The service’s team is educated in the factors that make a rehab program successful and are familiar with the issues that an addict will face in finding a treatment right for him or her.
Medical detoxification refers to an addict being medically monitored to ensure that they are cleansing their body of drugs in a safe way. Typically, detox will take anywhere from three to ten days, depending upon the drug that the addict uses, how often the drug is used, and how long the patient has been addicted. Depending upon these factors, most people can become physically and psychologically dependent upon the drug. When the drug use is abruptly discontinued, the addict may experience withdrawal symptoms such as cramping, sweats, anxiety, or even worse reactions like seizures may be present. Medications are provided to make the detox as painless as possible, and 24 hour nursing is available to monitor the addict’s detoxification. An addiction treatment center should have its own detox program in order to be the most successful.
A free standing residential addiction treatment center refers to a stand alone building that specializes in the treatment of addiction. Addicts reside in the center 24 hours a day and are under the care of addiction experts in order to make sure that their recovery is successful. Generally, patients will stay at a free standing residential addiction treatment center for about twenty days up to six months.
A hospital based addiction treatment program is located in a unit of a general hospital. This type of treatment program is best suited for a patient who has been dually diagnosed, meaning that in addition to their addiction, they have acute medical or psychiatric problems. Patients generally stay in these centers for a shorter period of time than they would stay in a free standing residential addiction treatment center.
These are just some of the treatment centers that are available to addicts. The experts at Recovery Connection can help you to determine which center is right for you. Finding the right drug or alcohol rehab program can be stressful, so let the experts at Recovery Connection help. They’ll ensure that you are connected with the most suitable program for your needs.
About Author
Recovery Connection is a popular tool for addicts who wish to find information regarding which addiction treatment program is right for them
Source: ArticleTrader.com
Drug Treatment Of Ventricular Tachycardia Specific links
Drug Treatment Of Ventricular Tachycardia News
St. Jude Medical Announces FDA Approval of Assura(TM) Implantable ... - MarketWatch (press release)
St. Jude Medical Announces FDA Approval of Assura(TM) Implantable ... MarketWatch (press release) The technology differentiates lead noise from true ventricular tachycardia (VT) or ventricular fibrillation (VF) episodes that require life-saving therapy. In addition, ShockGuard technology features specific programming that distinguishes between ... |
St. Jude Medical Announces FDA Approval of Smaller ICD with Physician Inspired ... - MarketWatch (press release)
St. Jude Medical Announces FDA Approval of Smaller ICD with Physician Inspired ... MarketWatch (press release) ICDs are advanced implantable devices that treat potentially lethal, abnormally fast heart rhythms (ventricular tachycardia or ventricular fibrillation) that often lead to sudden cardiac death (SCD). St. Jude Medical develops medical technology and ... St. Jude Medical Announces FDA Approval of Assura™ Implantable Defibrillators ... |
HRS: Anti-arrhythmics for VT/ICD: Do the benefits outweigh the risks? - Cardiovascular Business
HRS: Anti-arrhythmics for VT/ICD: Do the benefits outweigh the risks? Cardiovascular Business “I have patients with ventricular tachycardia [VT] who either aren't going to benefit from anti-arrhythmics or they will benefit from an ICD [implantable cardioverter-defibrillator],” said Dorian, director of the division of cardiology at the ... |
Fire Blotter: Man Falls Off Roof - Patch.com
Fire Blotter: Man Falls Off Roof Patch.com Paramedics performed advanced life support measures on scene to treat the super ventricular tachycardia; including 12-lead cardiac monitoring, intravenous access, drug therapy, and oxygen therapy. The patient was transported to Arcadia Methodist ... |
FDA Approves BIOTRONIK Next Generation ICDs and CRT-Ds - MarketWatch (press release)
FDA Approves BIOTRONIK Next Generation ICDs and CRT-Ds MarketWatch (press release) LAKE OSWEGO, Ore., May 10, 2012 (BUSINESS WIRE) -- BIOTRONIK, a leading manufacturer of innovative medical technology, has received FDA approval of its new Lumax 740 implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy ... |
Biosense Webster Announces Launch of the THERMOCOOL(R) SF NAV Catheter With ... - MarketWatch (press release)
Biosense Webster Announces Launch of the THERMOCOOL(R) SF NAV Catheter With ... MarketWatch (press release) The THERMOCOOL(R) SF NAV Catheter is approved in the United States for treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation when used with CARTO(R) Systems and Type 1 Atrial Flutter for patients 18 years and older. Biosense Webster Announces Launch Of The THERMOCOOL® SF NAV Catheter With ... JOHNSON & JOHNSON : Biosense Webster Announces Launch of the THERMOCOOL® SF ... |
FDA Approves BIOTRONIK Next Generation ICDs and CRT-Ds - EON: Enhanced Online News (press release)
FDA Approves BIOTRONIK Next Generation ICDs and CRT-Ds EON: Enhanced Online News (press release) (EON: Enhanced Online News)--BIOTRONIK, a leading manufacturer of innovative medical technology, has received FDA approval of its new Lumax 740 implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds). |
Biosense Webster Collaborates to Bring Innovative Solutions to ... - MarketWatch (press release)
Biosense Webster Collaborates to Bring Innovative Solutions to ... MarketWatch (press release) Cardiac ablation is a very common treatment for "simple" arrhythmias, like Wolff-Parkison-White Syndrome and atrioventricular nodal re-entry tachycardia (AVNRT), and is increasingly being used for more complex arrhythmias like ventricular tachycardia ... |
NEJM: Common antibiotic linked to a few CV deaths, prompting FDA review - Cardiovascular Business
NEJM: Common antibiotic linked to a few CV deaths, prompting FDA review Cardiovascular Business There was a small absolute increase in cardiovascular deaths, which was most pronounced among patients with a high baseline risk of cardiovascular disease during the five-day administration of the antibiotic azithromycin (Zithromax, Pfizer) therapy. |
One of Few Female Electrophysiologists Hones in On Heart Rhythm Disorders in Women - HealthCanal.com
One of Few Female Electrophysiologists Hones in On Heart Rhythm Disorders in Women HealthCanal.com Such events, known as ventricular tachycardia and ventricular fibrillation, usually occur after an individual's suffered a heart attack. The research, conducted in close collaboration with scientists in the Medical Center's Heart Research Follow-Up ... |